Skip to main content
⌘K
·
Launch Terminal
Launch Terminal
Home
SEC Filings
Home
SEC Filings
Filings
Filing Date
Form Type
Company
Description
AI
Link
Learn
MCP
API
Cookie Preferences
ATXI · Form 4 · Fortress Biotech, Inc. – AVENUE THERAPEUTICS, INC. | Signal8
Material events
Financial results
Capital raises
Insider transactions
Fund filings
Advanced filters
Any time
Sort
Filings
Filing Date
Form Type
Company
Description
AI
Link
Browse AI-analysed SEC filings
Page 1 of 76 · 7,550 total
AURE: SCHEDULE 13D/A · ownership disclosure
AURE · SCHEDULE 13D/A · 2026-10-27
GRML: S-1 · offering registration
GRML · S-1 · 2026-10-26
BEAG: 8-K · other
BEAG · 8-K · 2026-10-26
IQST: 8-K · debt financing
IQST · 8-K · 2026-10-26
CBK: 8-K · earnings release
CBK · 8-K · 2026-10-26
EVEX: 8-K · delisting
EVEX · 8-K · 2026-10-26
PHCI: 8-K · restatement
PHCI · 8-K · 2026-10-26
GGB: 6-K · dividend
GGB · 6-K · 2026-10-26
GGB: 6-K · earnings release
GGB · 6-K · 2026-10-26
WST: 8-K · debt financing
WST · 8-K · 2026-10-26
VENU: 8-K · material agreement
VENU · 8-K · 2026-10-26
AMUB: 424B3 · prospectus supplement
AMUB · 424B3 · 2026-10-26
GGB: 6-K · earnings release
GGB · 6-K · 2026-10-26
GRBK: 8-K · leadership change
GRBK · 8-K · 2026-10-26
AEYE: 10-Q · periodic report
AEYE · 10-Q · 2026-10-26
CYCU: 8-K · leadership change
CYCU · 8-K · 2026-10-26
DSY: 6-K · periodic report
DSY · 6-K · 2026-10-26
UBXG: 20-F · periodic report
UBXG · 20-F · 2026-10-26
PAX: 6-K · proxy statement
PAX · 6-K · 2026-10-26
BRO: 10-Q · periodic report
BRO · 10-Q · 2026-10-26
FLD: 424B3 · reverse split
FLD · 424B3 · 2026-10-26
FLD: 424B3 · reverse split
FLD · 424B3 · 2026-10-26
NE: 8-K · earnings release
NE · 8-K · 2026-10-26
BRO: 8-K · earnings release
BRO · 8-K · 2026-10-26
SLMT: SCHEDULE 13D/A · ownership disclosure
SLMT · SCHEDULE 13D/A · 2026-10-26
BBLG: 10-Q · periodic report
BBLG · 10-Q · 2026-10-26
WGRX: 8-K · acquisition merger
WGRX · 8-K · 2026-10-26
BRBS: 8-K · earnings release
BRBS · 8-K · 2026-10-26
YHNA: 8-K · delisting
YHNA · 8-K · 2026-10-26
CRML: 6-K · acquisition merger
CRML · 6-K · 2026-10-26
ZEO: 8-K · delisting
ZEO · 8-K · 2026-10-26
NUE: 8-K · earnings release
NUE · 8-K · 2026-10-26
BOH: 10-Q · periodic report
BOH · 10-Q · 2026-10-26
AMSS: 424B5 · prospectus supplement
AMSS · 424B5 · 2026-10-26
PULM: 424B3 · prospectus supplement
PULM · 424B3 · 2026-10-26
GNVR: 8-K · material agreement
GNVR · 8-K · 2026-10-26
SXI: 8-K · leadership change
SXI · 8-K · 2026-10-26
AMSS: 424B5 · prospectus supplement
AMSS · 424B5 · 2026-10-26
TRAW: S-1 · offering registration
TRAW · S-1 · 2026-10-26
DSY: 20-F · periodic report
DSY · 20-F · 2026-10-26
WHLR: 424B3 · reverse split
WHLR · 424B3 · 2026-10-26
CEPU: 6-K · share repurchase
CEPU · 6-K · 2026-10-26
WHLR: 424B3 · reverse split
WHLR · 424B3 · 2026-10-26
R: 424B3 · debt financing
R · 424B3 · 2026-10-26
SDEV: S-3/A · shelf registration
SDEV · S-3/A · 2026-10-26
FLXS: 8-K · earnings release
FLXS · 8-K · 2026-10-26
WEAV: 8-K · acquisition merger
WEAV · 8-K · 2026-10-26
WHLR: 424B3 · reverse split
WHLR · 424B3 · 2026-10-26
XHLD: 424B3 · shelf registration
XHLD · 424B3 · 2026-10-26
GLASF: 6-K · earnings release
GLASF · 6-K · 2026-10-26
SLBT: 6-K · earnings release
SLBT · 6-K · 2026-10-26
TBI: 8-K · leadership change
TBI · 8-K · 2026-10-26
NEWH: 8-K · material agreement
NEWH · 8-K · 2026-10-26
DHI: 8-K · leadership change
DHI · 8-K · 2026-10-26
FSUN: 8-K · earnings release
FSUN · 8-K · 2026-10-26
HTO: 10-Q · periodic report
HTO · 10-Q · 2026-10-26
HIT: 8-K · leadership change
HIT · 8-K · 2026-10-26
WELL: 8-K · earnings release
WELL · 8-K · 2026-10-26
LAZ: 10-Q · periodic report
LAZ · 10-Q · 2026-10-26
DORM: 8-K · earnings release
DORM · 8-K · 2026-10-26
MAAS: 20-F · periodic report
MAAS · 20-F · 2026-10-26
UUU: S-3 · shelf registration
UUU · S-3 · 2026-10-26
DEA: 10-Q · periodic report
DEA · 10-Q · 2026-10-26
VRME: 8-K · earnings release
VRME · 8-K · 2026-10-26
NTCL: 6-K · reverse split
NTCL · 6-K · 2026-10-26
FDUS: 8-K · debt financing
FDUS · 8-K · 2026-10-26
CLWT: 6-K · proxy statement
CLWT · 6-K · 2026-10-26
MCRB: 8-K · leadership change
MCRB · 8-K · 2026-10-26
UTL: 8-K · debt financing
UTL · 8-K · 2026-10-26
AZULQ: SCHEDULE 13D · ownership disclosure
AZULQ · SCHEDULE 13D · 2026-10-26
HTO: 8-K · earnings release
HTO · 8-K · 2026-10-26
GABC: 8-K · earnings release
GABC · 8-K · 2026-10-26
CLS: 10-Q · periodic report
CLS · 10-Q · 2026-10-26
AZO: 10-K · periodic report
AZO · 10-K · 2026-10-26
CFFI: 8-K · earnings release
CFFI · 8-K · 2026-10-26
JBLU: 10-Q · periodic report
JBLU · 10-Q · 2026-10-26
CLS: 8-K · earnings release
CLS · 8-K · 2026-10-26
ABOS: S-3 · shelf registration
ABOS · S-3 · 2026-10-26
MYSZ: S-3 · shelf registration
MYSZ · S-3 · 2026-10-26
NDAQ: 8-K · leadership change
NDAQ · 8-K · 2026-10-26
PDM: 8-K · earnings release
PDM · 8-K · 2026-10-26
GAIN: 8-K · leadership change
GAIN · 8-K · 2026-10-26
PDM: 10-Q · periodic report
PDM · 10-Q · 2026-10-26
PECO: 8-K · earnings release
PECO · 8-K · 2026-10-26
SSD: 8-K · earnings release
SSD · 8-K · 2026-10-26
PRK: 8-K · earnings release
PRK · 8-K · 2026-10-26
SNTI: 8-K · acquisition merger
SNTI · 8-K · 2026-10-26
WDFC: 10-K · periodic report
WDFC · 10-K · 2026-10-26
GLAD: 8-K · leadership change
GLAD · 8-K · 2026-10-26
AGRO: 6-K · dividend
AGRO · 6-K · 2026-10-26
GBX: 10-K · periodic report
GBX · 10-K · 2026-10-26
LAND: 8-K · leadership change
LAND · 8-K · 2026-10-26
JBLU: 8-K · earnings release
JBLU · 8-K · 2026-10-26
CTOS: 10-Q · periodic report
CTOS · 10-Q · 2026-10-26
GOOD: 8-K · leadership change
GOOD · 8-K · 2026-10-26
ETST: 8-K · leadership change
ETST · 8-K · 2026-10-26
PSA: 10-Q · periodic report
PSA · 10-Q · 2026-10-26
MYSZ: 8-K · leadership change
MYSZ · 8-K · 2026-10-26
NTCT: 8-K · leadership change
NTCT · 8-K · 2026-10-26
TH: SCHEDULE 13D/A · ownership disclosure
TH · SCHEDULE 13D/A · 2026-10-26
1
2
3
4
8
12
16
20
24
28
32
36
40
44
48
52
56
60
64
68
72
76
Next ›
